InvestorsHub Logo
Followers 46
Posts 3151
Boards Moderated 0
Alias Born 05/22/2010

Re: None

Tuesday, 11/09/2021 10:31:35 PM

Tuesday, November 09, 2021 10:31:35 PM

Post# of 402943
Mr Ehrlich intentions clearly stated in Q10:
Business Development and Licensing

The Company is actively engaged in business development and licensing initiatives with multiple specialty and global pharmaceutical companies. From time to time, the Company may be party to various indications of interest and term sheets and participate in preliminary discussions and negotiations regarding potential licensing or partnership arrangements. It remains the Company’s primary objective to complete licensing deals, territorial and/or global, to provide access to non-dilutive capital to advance clinical assets forward in the most expeditious and cost-effective manner. The Company can make no assurance that partnerships will occur, but is committed toward executing on these potential alliance and partnership opportunities.

I really like Leo’s business savy as seen in this statement. RA Phillips
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News